Cargando…
Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome
Background and Aims. Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the sp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011218/ https://www.ncbi.nlm.nih.gov/pubmed/27635130 http://dx.doi.org/10.1155/2016/9256209 |
_version_ | 1782451787059429376 |
---|---|
author | Tao, Wenhua Dong, Xiaoyun Kong, Guimei Fang, Penghua Huang, Xiaoli Bo, Ping |
author_facet | Tao, Wenhua Dong, Xiaoyun Kong, Guimei Fang, Penghua Huang, Xiaoli Bo, Ping |
author_sort | Tao, Wenhua |
collection | PubMed |
description | Background and Aims. Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the specific expression of miRNAs in diabetes with D-IBS is identified in the study. Materials and Methods. 201 patients with IBS and 220 matched healthy controls were included in the study. Microarray technology and real-time reverse transcriptase-polymerase chain reaction analysis (RT-PCR) were taken to examine the miRNA expression profiles of T2DM patients with diarrhea-predominant irritable bowel syndrome (D-IBS) compared with patients with T2DM, patients with D-IBS, and control subjects. Results. We have found that 35 miRNAs were differentially expressed in T2DM with D-IBS, in which three representative miRNAs, hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b, were found to be significantly elevated in T2DM with D-IBS by RT-PCR. Conclusions. Our study has indicated that hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b were elevated in T2DM with D-IBS, which may be the potential biomarkers of T2DM with D-IBS. To obtain a better understanding of the biological functions of these miRNAs in T2DM with D-IBS, functional annotation analysis suggested that the MAPK pathway may be responsible for T2DM with D-IBS. |
format | Online Article Text |
id | pubmed-5011218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50112182016-09-15 Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome Tao, Wenhua Dong, Xiaoyun Kong, Guimei Fang, Penghua Huang, Xiaoli Bo, Ping Gastroenterol Res Pract Research Article Background and Aims. Although the differential expression of microRNA (miRNA) genes has been identified in many diseases, little information exists concerning the miRNA expression profile in type 2 diabetes mellitus (T2DM) with diarrhea-predominant irritable bowel syndrome (D-IBS). Therefore, the specific expression of miRNAs in diabetes with D-IBS is identified in the study. Materials and Methods. 201 patients with IBS and 220 matched healthy controls were included in the study. Microarray technology and real-time reverse transcriptase-polymerase chain reaction analysis (RT-PCR) were taken to examine the miRNA expression profiles of T2DM patients with diarrhea-predominant irritable bowel syndrome (D-IBS) compared with patients with T2DM, patients with D-IBS, and control subjects. Results. We have found that 35 miRNAs were differentially expressed in T2DM with D-IBS, in which three representative miRNAs, hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b, were found to be significantly elevated in T2DM with D-IBS by RT-PCR. Conclusions. Our study has indicated that hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b were elevated in T2DM with D-IBS, which may be the potential biomarkers of T2DM with D-IBS. To obtain a better understanding of the biological functions of these miRNAs in T2DM with D-IBS, functional annotation analysis suggested that the MAPK pathway may be responsible for T2DM with D-IBS. Hindawi Publishing Corporation 2016 2016-08-22 /pmc/articles/PMC5011218/ /pubmed/27635130 http://dx.doi.org/10.1155/2016/9256209 Text en Copyright © 2016 Wenhua Tao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tao, Wenhua Dong, Xiaoyun Kong, Guimei Fang, Penghua Huang, Xiaoli Bo, Ping Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
title | Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
title_full | Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
title_fullStr | Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
title_full_unstemmed | Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
title_short | Elevated Circulating hsa-miR-106b, hsa-miR-26a, and hsa-miR-29b in Type 2 Diabetes Mellitus with Diarrhea-Predominant Irritable Bowel Syndrome |
title_sort | elevated circulating hsa-mir-106b, hsa-mir-26a, and hsa-mir-29b in type 2 diabetes mellitus with diarrhea-predominant irritable bowel syndrome |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011218/ https://www.ncbi.nlm.nih.gov/pubmed/27635130 http://dx.doi.org/10.1155/2016/9256209 |
work_keys_str_mv | AT taowenhua elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome AT dongxiaoyun elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome AT kongguimei elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome AT fangpenghua elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome AT huangxiaoli elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome AT boping elevatedcirculatinghsamir106bhsamir26aandhsamir29bintype2diabetesmellituswithdiarrheapredominantirritablebowelsyndrome |